Atlas Trials

Trial of the Rapid Antisuicidal Effects of Intranasal Ketamine in Comorbid Depression and Alcohol Abuse

Clinical trial NCT03539887 · COMPLETED

Trial details

NCT number
NCT03539887
Sponsor
The University of Texas Health Science Center, Houston
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Suicidal IdeationDepressionAlcohol Abuse
Start date
2018-05-01
Primary completion
2022-01-15
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.